Skip to main content

Table 2 Univariable and multivariable analysis for not being included in cancer patient pathways among colorectal, lung, breast and prostate cancer patients diagnosed in 2015–2016 in Norway

From: Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

 

Colorectal

Lung

Breast

Prostate

Univariate

Multivariate

Univariate

Multivariate

Univariate

Multivariate

Univariate

Multivariate

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

OR [95%CI]*

Year of diagnosis

 2015

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 2016

0.61 [0.55,0.69]

0.60 [0.54,0.68]

0.58 [0.51,0.66]

0.55 [0.47,0.63]

0.33 [0.27,0.41]

0.31 [0.25,0.39]

0.56 [0.51,0.61]

0.51 [0.47,0.56]

 p-value

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

Age group

 18–49

2.34 [1.81,3.04]

2.23 [1.70,2.91]

1.06 [0.63,1.78]

1.18 [0.69,2.01]

0.75 [0.55,1.02]

0.77 [0.56,1.06]

0.82 [0.53,1.25]

0.75 [0.48,1.16]

 50–59

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 60–69

0.92 [0.74,1.14]

0.89 [0.72,1.11]

1.02 [0.78,1.33]

1.00 [0.76,1.32]

0.91 [0.70,1.18]

0.88 [0.67,1.15]

0.89 [0.77,1.03]

0.94 [0.81,1.09]

 70–79

1.00 [0.82,1.23]

0.93 [0.75,1.16]

1.19 [0.92,1.54]

1.11 [0.85,1.45]

1.00 [0.74,1.35]

0.79 [0.57,1.10]

1.37 [1.19,1.59]

1.58 [1.35,1.85]

 80–89

1.32 [1.07,1.63]

1.15 [0.92,1.45]

2.63 [2.01,3.44]

2.21 [1.67,2.94]

1.13 [0.80,1.61]

0.74 [0.49,1.10]

4.46 [3.75,5.31]

5.59 [4.60,6.78]

 90+

3.31 [2.48,4.41]

2.50 [1.83,3.40]

5.39 [3.40,8.55]

4.68 [2.87,7.63]

1.45 [0.84,2.52]

0.92 [0.50,1.68]

14.0 [8.8,22.3]

17.3[10.7,28.0]

 p-value

< 0.001

< 0.001

< 0.001

< 0.001

0.138

0.509

< 0.001

< 0.001

Sex

 Female

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

  

 Male

0.87 [0.78,0.97]

0.93 [0.83,1.05]

0.91 [0.80,1.04]

0.86 [0.75,0.99]

  

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 p-value

0.014

0.240

0.152

0.040

    

Stagea

 A

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 B

0.58 [0.50,0.67]

0.57 [0.49,0.66]

1.34 [1.04,1.74]

1.41 [1.09,1.83]

1.01 [0.72,1.40]

1.02 [0.73,1.43]

0.52 [0.46,0.57]

0.44 [0.39,0.49]

 C

1.20 [1.03,1.41]

1.19 [1.01,1.40]

3.25 [2.59,4.08]

3.44 [2.72,4.35]

5.21 [3.77,7.20]

5.94 [4.20,8.40]

1.24 [1.04,1.47]

0.74 [0.61,0.89]

 D

1.41 [1.14,1.73]

1.22 [0.98,1.52]

4.28 [3.31,5.54]

4.08 [3.12,5.32]

3.33 [2.45,4.51]

3.36 [2.41,4.68]

0.86 [0.76,0.96]

0.69 [0.61,0.78]

 p-value

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

Marital status

 Single

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 Married

0.71 [0.64,0.79]

0.81 [0.72,0.92]

0.82 [0.72,0.94]

0.93 [0.81,1.08]

1.02 [0.84,1.23]

1.03 [0.83,1.28]

0.89 [0.81,0.97]

0.89 [0.80,0.98]

 p-value

< 0.001

< 0.001

0.003

0.351

0.870

0.776

0.010

0.022

Education

 Low

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 Intermediate

0.84 [0.74,0.95]

0.95 [0.83,1.09]

0.85 [0.74,0.98]

0.96 [0.83,1.12]

0.84 [0.66,1.06]

0.92 [0.72,1.18]

0.79 [0.71,0.88]

0.92 [0.82,1.04]

 High

0.85 [0.73,0.99]

0.98 [0.82,1.17]

0.71 [0.57,0.89]

0.88 [0.68,1.13]

0.75 [0.58,0.96]

0.97 [0.72,1.31]

0.81 [0.72,0.92]

1.03 [0.89,1.18]

 p-value

0.015

0.770

0.004

0.592

0.079

0.796

< 0.001

0.120

Income

 Low

1.29 [1.07,1.55]

1.24 [1.00,1.54]

1.97 [1.55,2.51]

1.52 [1.16,1.99]

1.72 [1.27,2.33]

1.42 [0.99,2.03]

1.72 [1.47,2.02]

1.05 [0.87,1.27]

 Intermediate

1.15 [1.00,1.32]

1.13 [0.97,1.33]

1.47 [1.21,1.81]

1.16 [0.93,1.45]

1.39 [1.13,1.72]

1.21 [0.94,1.54]

1.29 [1.18,1.42]

0.94 [0.84,1.05]

 High

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 p-value

0.025

0.146

< 0.001

0.004

< 0.001

0.135

< 0.001

0.310

Regionb

 South-East

1.10 [1.04,1.16]

1.11 [1.05,1.17]

1.07 [1.01,1.14]

1.08 [1.01,1.15]

0.85 [0.78,0.93]

0.85 [0.78,0.93]

0.95 [0.91,0.98]

0.96 [0.92,1.00]

 West

0.93 [0.83,1.04]

0.93 [0.83,1.04]

0.99 [0.88,1.13]

1.01 [0.88,1.15]

1.12 [0.92,1.36]

1.09 [0.89,1.33]

1.41 [1.30,1.53]

1.39 [1.27,1.51]

 Mid

1.10 [0.97,1.25]

1.09 [0.95,1.25]

1.21 [1.02,1.42]

1.22 [1.02,1.45]

2.67 [2.22,3.21]

2.82 [2.32,3.43]

0.76 [0.68,0.85]

0.75 [0.67,0.84]

 North

0.62 [0.51,0.75]

0.59 [0.49,0.72]

0.55 [0.44,0.70]

0.52 [0.41,0.66]

0.48 [0.31,0.75]

0.48 [0.31,0.75]

1.02 [0.89,1.17]

1.04 [0.89,1.20]

 p-value

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

Comorbidity

        

 No admissions

1.01 [0.75,1.36]

0.97 [0.71,1.32]

0.53 [0.26,1.06]

0.48 [0.23,0.97]

0.74 [0.58,0.96]

0.90 [0.69,1.17]

1.76 [1.55,2.00]

2.00 [1.75,2.29]

 0

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

1.00 [1.00,1.00]

 1–2

1.21 [1.06,1.39]

1.18 [1.02,1.36]

1.23 [1.07,1.41]

1.28 [1.10,1.49]

1.09 [0.79,1.51]

1.07 [0.75,1.51]

1.65 [1.47,1.85]

1.38 [1.22,1.56]

 3+

1.83 [1.42,2.36]

1.67 [1.28,2.18]

1.95 [1.55,2.45]

1.90 [1.48,2.44]

1.94 [1.02,3.68]

1.09 [0.54,2.19]

3.24 [2.52,4.17]

2.31 [1.75,3.06]

 p-value

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

  1. aColorectal, lung and prostate: Localised (A), Regional (B), Metastasis (C), Unknown (D). Breast: Stage I-II (A), Stage III (B), Stage IV (C), Unknown (D)
  2. bCompared with Norway (mean)
  3. *Odds Ratio [95% c onfidence interval]